Prescription drug · NDA
Dronabinol NDC 85776-202
Dronabinol 5 mg/mL · Solution · Oral · Wellhouse Pharma, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 85776-202-30 | 85776020230 | 1 BOTTLE, GLASS in 1 CARTON (85776-202-30) / 30 mL in 1 BOTTLE, GLASSMarketed from Feb 11, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Dronabinol
- Generic name (nonproprietary)
- dronabinol
- Active ingredients
- Dronabinol — 5 mg/mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- Wellhouse Pharma, LLC
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 205525
- Marketing start
- Listing expires
- DEA schedule
- CII
- Other FDA classes
- Cannabinoids (Chemical structure)
- Identifiers
- Product ID 85776-202_818b1821-a561-4dda-87ff-a0311ef7d11aSPL ID 818b1821-a561-4dda-87ff-a0311ef7d11aSPL set ID 495aabae-3597-49dc-a5af-e328bcd937b7RxCUI 1928948UNII 7J8897W37SUPC 0385776202309
- Pharmacologic class
- Cannabinoid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N485776020230followed by a unit qualifier and the quantityPackage 85776-0202-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Dronabinol oral solution is indicated in adults for the treatment of: anorexia associated with weight loss in patients with Acquired Immune Deficiency Syndrome (AIDS). nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. Dronabinol oral solution is a cannabinoid indicated in adults for the treatment of: anorexia associated with weight loss in patients with AIDS. ( 1 ) nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 205525
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Dronabinol | Dronabinol 5 mg/mL | SolutionOral | Chartwell RX, LLC | 62135-033 |
| Syndrosdronabinol | Dronabinol 5 mg/mL | SolutionOral | Wellhouse Pharma, LLC | 85776-201 |
| Syndrosdronabinol | Dronabinol 5 mg/mL | SolutionOral | Benuvia Operations, LLC | 78613-201 |